Astec LifeSciences Limited (ASTEC) has announced its financial results for Q2 and H1 of FY27, revealing a challenging performance. The company reported a consolidated total income of ₹72.6 crore in Q2 FY27 compared to ₹74.8 crore in the same period last year, marking a 3% decrease. The consolidated EBITDA stood at (₹19.2 crore) in Q2 FY27 versus (₹5.6 crore) in Q2 FY26, indicating a significant deterioration.

Financial Overview

ASTEC’s consolidated total income for H1 FY27 was ₹156.9 crore, down from ₹166.4 crore in H1 FY26, reflecting a 6% decline. The company’s EBITDA for H1 FY27 was (₹19.1 crore) compared to (₹16.1 crore) in H1 FY26. The reported loss after tax for Q2 FY27 was (₹37.4 crore), up from (₹24.4 crore) in Q2 FY26. For H1 FY27, the loss after tax was (₹56.1 crore) compared to (₹57.4 crore) in H1 FY26.

Impact of Adverse Conditions

Commenting on the performance, Mr. Vishal Sharma, Chairperson of ASTEC, attributed the decline to adverse weather conditions, elevated channel inventories, and cautious procurement by customers. The El Niño impact and poor rainfall in many parts of India have weakened demand. Export sales were further impacted by channel destocking, pricing pressure, and weaker demand in select export markets.

Looking Ahead

ASTEC is focused on expanding its growth platform through enhanced business development efforts and new product introductions. The company aims to improve capacity utilizations, optimize costs, and strengthen operational performance to navigate through the current challenges.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Astec LifeSciences Limited

Astec LifeSciences Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

Astec moves sideways over three months, with neither buyers nor sellers taking control. D/E reaches 2.36. High leverage in this environment is a material risk the market cannot ignore. Margins of 15.1% are above average but show signs of plateauing — watch for further pressure. The stock holds at 46% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at -10.8% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of Astec LifeSciences Limited.

Dalmia Bharat Limited (NSE: DALBHARAT), a leading cement manufacturing company, reported its consolidated financial results for the quarter and half year ended September 30, 2026. Despite global headwinds, the company showcased steady performance with key highlights including strong progress on integration of central assets, a trial run at the 3.6 MnTPA Belgaum Clinker line ahead of schedule, and a 4% YoY revenue increase to Rs 3,563 Cr.

Financial Performance

EBITDA stood at Rs 493 Cr, impacted by cost headwinds, but the company remains optimistic about mitigating these pressures through strategic initiatives. The share of renewable power consumption rose to 52%, reflecting the company’s commitment to sustainability.

Strategic Milestones

The company has initiated trial runs at its expansion projects and continues to advance its capacity expansion plans. The resolution plan for acquiring BJCL has been approved, marking significant progress in its growth strategy. Additionally, Dalmia Bharat Limited has declared an interim dividend of Rs 4 per share, underscoring its focus on delivering value to shareholders.

Looking Ahead

Commenting on the performance, Mr. Puneet Dalmia, Managing Director & CEO, emphasized the company’s resilience and strategic focus on operational excellence and financial discipline to ensure sustainable growth. The company remains committed to executing its strategic priorities and achieving long-term industry prospects.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Dalmia Bharat Limited

Dalmia Bharat Limited belongs to the Basic Materials › Building Materials sector. Here’s a quick read on where the business and the stock stand today.

Dalmia trades in the lower quarter of its 52-week range. The PEG stands at 9.31 — severely stretched. Any earnings miss could trigger a sharp de-rating. Thin margins at 7.7% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock gains 4.5% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 3.8% yet the PEG reaches 9.31 — expensive for that growth. Furthermore, the stock drops 7.7% in three months. Neither value nor momentum supports this setup. It needs an earnings beat or a price reset first. Check Fundamentals of Dalmia Bharat Limited.

Cubex Tubings Limited, a manufacturer of seamless copper and copper alloy tubes, rods, and wires for critical industrial applications, yesterday announced its unaudited standalone financial results for the second quarter and half-year ended 30 September 2026. The quarter delivered a sharp step-up in revenue and profitability, with growth across the core copper alloy range and a marked improvement in operating margin.

Revenue and Profitability

Revenue from operations stood at ₹82.99 crore, up 28% QoQ. The EBITDA margin improved to 8.62%, a significant 645 bps QoQ. Profit after tax rose 235% QoQ to ₹7.15 crore. The annualised return on equity for H1 FY27 was 21.2% against 8.9% for FY26, and the annualised return on capital employed was 22.7% against 10.7%.

Balance Sheet and Capital Structure

Net worth stood at ₹89.2 crore as of 30 September 2026, up from ₹83.3 crore as of 31 March 2026. Total borrowings of ₹44.3 crore were broadly stable, with a shift towards long-term funding.

Mr. Virendra Bhandari, Managing Director, Cubex Tubings Limited, stated: ‘The second quarter reflects the two things we set out to do this year: grow volumes in our established copper alloy business and improve the mix towards higher-value seamless products. Revenue grew 28%, EBITDA more than doubled, and profit after tax rose 235%, with EBITDA margin at 8.62%.’

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Cubex Tubings Limited

Cubex Tubings Limited belongs to the Basic Materials › Copper sector. Here’s a quick read on where the business and the stock stand today.

Cubex gains 183.8% over three months and trades near its 52-week highs. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Revenue grows at 14.7% and profits at 41.2% CAGR. However, that pace does not justify a premium multiple. RSI hits 86, a level that signals the stock runs hot. Notably, buyers drove volume on 22 recent sessions — though at these levels, some profit-taking is normal. The stock rises 183.8% in three months on 14.7% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cubex Tubings Limited.